United States - English - NLM (National Library of Medicine)

grifols usa, llc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 12.5 g in 50 ml - for restoration and maintenance of circulating blood volume where hypovolemia is demonstrated and colloid use is appropriate. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20-25% albumin solutions should be used.1,2,3 acute liver failure is a special situation in which both hypovolemia and hypoalbuminemia can be present. human albumin grifols® 25% can be used in such cases.1 human albumin grifols 25% may be of value in the treatment of shock or hypotension in renal dialysis patients.1 preoperative dilution of blood using albumin and crystalloid can be used in cardiopulmonary bypass procedures. albumin also may be used in the priming fluid.4,5,6 human albumin grifols 25% may be used to treat peripheral edema in patients with acute nephrosis who are refractory to cyclophosphamide, corticosteroid therapy or diuretics.1,2,7 human albumin grifols 25% may be indicated for subjects with hypoalbuminemia who are critically ill and/or actively bleeding. when

Canada - English - Health Canada

octapharma pharmazeutika produktionsges m b h - fibrinogen (human) - powder for solution - 1g - fibrinogen (human) 1g - hemostatics

Canada - English - Health Canada

csl behring canada inc - fibrinogen (human) - powder for solution - 1000mg - fibrinogen (human) 1000mg - hemostatics

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

baxter sa-nv - human fibrinogen humain 72 mg/ml - 110 mg/ml (component 1); factor xiii 0,6 iu/ml - 10 iu/ml (component 1); aprotinin (component 1); human thrombin 500 iu/ml (component 2); calcium chloride dihydrate - eq. calcium chloride quantum satis (component 2) - solution for sealant - 4 ml - human fibrinogen; factor xiii; human thrombin; aprotinin; calcium chloride dihydrate - combinations

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

baxter sa-nv - human fibrinogen humain 72 mg/ml - 110 mg/ml (component 1); factor xiii 0,6 iu/ml - 10 iu/ml (component 1); aprotinin (component 1); human thrombin 500 iu/ml (component 2); calcium chloride dihydrate - eq. calcium chloride quantum satis (component 2) - solution for sealant - 10 ml - human fibrinogen; factor xiii; human thrombin; aprotinin; calcium chloride dihydrate - combinations

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - human parvovirus b19 (unii: 94n635564t) (human parvovirus b19 - unii:94n635564t) - human parvovirus b19 15 in 1 ml - for the temporary relief of symptoms related to parvovirus including rash, swollen, painful joints and fever.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for the temporary relief of symptoms related to parvovirus including rash, swollen, painful joints and fever.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc - human parvovirus b19 (unii: 94n635564t) (human parvovirus b19 - unii:94n635564t) - human parvovirus b19 15 [hp_x] in 1 ml - for the temporary relief of symptoms related to parvovirus including rash, swollen, painful joints and fever.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration. for the temporary relief of symptoms related to parvovirus including rash, swollen, painful joints and fever.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

apotheca company - human parvovirus b19 (unii: 94n635564t) (human parvovirus b19 - unii:94n635564t) - human parvovirus b19 15 [hp_x] in 1 ml -     indications:  for the temporary relief of symptoms related to parvovirus including rash, swollen, painful joints and fever. indications:   for the temporary relief of symptoms related to parvovirus including rash, swollen, painful joints and fever.

Malta - English - Medicines Authority

octapharma (ip) limited - human von willebrand factor; human coagulation factor xiii - powder and solvent for solution for injection - human von willebrand factor 1000 iu; human coagulation factor xiii 1000 iu - antihemorrhagics

Malta - English - Medicines Authority

octapharma (ip) limited - human von willebrand factor; human coagulation factor viii - powder and solvent for solution for injection - human von willebrand factor 500 iu; human coagulation factor viii 500 iu - antihemorrhagics